KRISTEN ABBOTT: Open Payments
NPI 1700597382 · BERLIN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 52 payments from 19 companies in 2025. Trend: 2023 $527 · 2024 $1,257 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $176 |
| Merck Sharp & Dohme LLC | 4 | $120 |
| PFIZER INC. | 5 | $117 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Lilly USA, LLC | 3 | $66 |
| Exact Sciences Corporation | 3 | $60 |
| Neurocrine BioSciences, Inc. | 3 | $58 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Amgen Inc. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
Products named: VRAYLAR, GARDASIL 9, PREVNAR 20, MOUNJARO, Cologuard Collection Kit, INGREZZA, QULIPTA, VOWST.
Industry payments across MD — which companies pay providers there.
